glp-1 telehealth crackdown news today FEDS CRACK DOWN ON COMPANIES SELLING GLP-1s: The U.S. Food and Drug Administration is cracking down on telehealth companies for making “false and misleading” claims about compounded versions of popular weight Troubling Findings in Study of

The review from AL-Noshokaty and colleagues was published in Toxicology Reports .

Peptides for weight loss include GLP-1 receptor agonist medications such as Wegovy and Saxenda, as well as dual GIP/GLP-1 receptor agonists like Zepbound

For example, individuals preparing for bariatric surgery may benefit from GLP-1 or tirzepatide based therapies that reduce liver size and improve surgical safety

Drug Saf

If your next dose is less than 2 days away: Skip the missed dose and take your next dose on the regularly scheduled day

Our team provides individualized evaluations to determine the safest and most appropriate plan for achieving sustainable weight loss